New Tool Estimates Amyloid Risk in Early Alzheimer’s
News article published on Conexiant about Cognivue's value-add component now integrated into the Cognivue Clarity tool—The Cognivue Amyloid Risk Measure (CARM)*—a cognitive performance–based score that stratifies older adults by predicting likelihood of risk of cerebral amyloid deposition.
Clinical Application and Potential of Cognitive Amyloid Risk Measure: James Galvin, MD, MPH
News article and an explanatory video published on NeurologyLive. In it, Dr. James Galvin, MD, MPH, Chief Scientific Officer at Cognivue, gives an informative explanation of the clinical application of Cognivue’s new prediction metric, the Cognivue Amyloid Risk Measure (CARM).*
